Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Vorinostat × Clear all

NCT01501370 2016-05-10

ZLd_Ld

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02114502 2014-07-11

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell